The heavy cost of the weight-loss craze
Thanks to the extreme weight-loss craze care of GLP-1 drugs, fashion retailers are facing an unprecedented challenge: rapidly changing body sizes. On June 8, marketing site Filter Coffee Co. writes:
Fashion companies… spend months predicting exactly what clothes people will need.
If a growing number of customers suddenly move from XL to L, from L to M, or from M to S within a year, those forecasts start breaking down.
Some analysts now estimate that US apparel retailers could face inventory mismatches worth almost ₹42,000 crore ($5 billion) by 2027 if they fail to adjust to changing body-size patterns.
There is also a deeper cultural shift taking place.
Our November 2025 issue of The Socionomist breaks the issue down and reveals why Ozempic didn’t cause this deep cultural shift; social mood did.
Read our full cover story “Does Social Mood Have Body Issues?” — along with the complete November 2025 Socionomist — for just $30!